Agenzia Italiana del Farmaco
Home
Giovedì 15 aprile p.v. alle 15.30 si svolgerà il secondo seminario scientifico dal titolo “Causalità e casualità nei recenti segnali di farmacovigilanza dei vaccini Covid-19: quali evidenze per le decisioni di salute pubblica?”
Press release no. 641 - The data analysis was competed of the randomised and controlled clinical trial called TSUNAMI, promoted by the ISS and AIFA and coordinated by the ISS, on the therapeutic role of convalescent plasma in patients who have developed the COVID-19 disease.
The reports analyse trends in consumption and expenditure and regional variability in the use of biosimilars in Italy.
Press release no. 640 - The Italian Medicines Agency presented the first OsMed Report on the parallel import and export of medicines for human use.
Medicines alerts
AIFA Focus
"Do you want to know more about COVID-19 vaccines?"
15 April
da definire
15 April
13:30
16 April
da definire
Consult the list of insolvency procedures for the recruitment of personnel.
Competitions
Go to the section that collects information on purchasing procedures.